Update on endogenous inhibitors of angiogenesis

Endothelium: Journal of Endothelial Cell Research

Volumn 13, Issue 2, 2006, Pages 147-155

  Sato, Yasufumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; Degradation products; Gene products; Metabolites

Indexed keywords

2 METHOXYESTRADIOL; ALPHA INTERFERON; ANGIOGENESIS INHIBITOR; ANGIOPOIETIN; ANGIOSTATIN; ANTITHROMBIN; BETA INTERFERON; CANSTATIN; CELL PROTEIN; CHONDROMODULIN I; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; MASPIN; PIGMENT EPITHELIUM DERIVED FACTOR; PROLACTIN; PROTEOHEPARAN SULFATE; RETINA S ANTIGEN; SCLEROPROTEIN; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASOHIBIN; VASOSTATIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; CELL DIFFERENTIATION; CELL GROWTH; ENDOTHELIUM CELL; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENETIC CODE; GENOME; HUMAN; METABOLITE; MOLECULAR GENETICS; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW;

ANGIOGENESIS INHIBITORS; ANGIOGENIC PROTEINS; ANIMALS; EXTRACELLULAR MATRIX; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE HYDROLASES;

EID: 33746844372     PISSN: 10623329     EISSN: 10292373     Source Type: Journal    
DOI: 10.1080/1062332060069110     Document Type: Review

References (100)

1. Abe, M. and Sato, Y. (2001) cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells Angiogenesis, 4, pp. 289-298. [INFOTRIEVE] [CSA]
2. Bein, K. and Simons, M. (2000) Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity Journal of Biological Chemistry, 275, pp. 32167-32173. [INFOTRIEVE] [CSA] [CROSSREF]
3. Bergers, G. and Brekken, R. and McMahon, G. and Vu, T. and Itoh, T. and Tamaki, K. and Tanzawa, K. and Thorpe, P. and Itohara, S. and Werb, Z. and Hanahan, D. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Nature Cell Biology, 2, pp. 737-744. [INFOTRIEVE] [CSA] [CROSSREF]
4. Biliran, H., Jr. and Sheng, S. (2001) Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin Cancer Research, 61, pp. 8676-8682. [INFOTRIEVE] [CSA]
5. Brew, K. and Dinakarpandian, D. and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function Biochimica et Biophysica Acta, 1477, pp. 267-283. [INFOTRIEVE] [CSA]
6. Chadderton, N. and Stringer, S. (2003) Interaction of platelet factor 4 with fibroblast growth factor 2 is stabilised by heparan sulphate International Journal of Biochemistry and Cell Biology, 35, pp. 1052-1055. [INFOTRIEVE] [CSA] [CROSSREF]
7. Chen, H. and Herndon, M. and Lawler, J. (2000) The cell biology of thrombospondin-1 Matrix Biology, 19, pp. 597-614. [INFOTRIEVE] [CSA] [CROSSREF]
8. Clark, D. and Smith, S. and He, Y. and Day, K. and Licence, D. and Corps, A and Lammoglia, R. and Charnock-Jones, D. (1998) A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation Biology of Reproduction, 59, pp. 1540-1548. [INFOTRIEVE] [CSA] [CROSSREF]
9. Coljee, V. and Rotenberg, M. and Tresini, M. and Francis, M. and Cristofalo, V. and Sell, C. (2000) Regulation of EPC-1/PEDF in normal human fibroblasts is posttranscriptional Journal of Cellular Biochemistry, 79, pp. 442-452. [INFOTRIEVE] [CSA] [CROSSREF]
10. Colorado, P. and Torre, A. and Kamphaus, G. and Maeshima, Y. and Hopfer, H. and Takahashi, K. and Volk, R. and Zamborsky, E. and Herman, S. and Sarkar, P. and Ericksen, M. and Dhanabal, M. and Simons, M. and Post, M. and Kufe, D. and Weichselbaum, R. and Sukhatme, V. and Kalluri, R. (2000) Anti-angiogenic cues from vascular basement membrane collagen Cancer Research, 60, pp. 2520-2526. [INFOTRIEVE] [CSA]
11. Cornelius, L. and Nehring, L. and Harding, E. and Bolanowski, M. and Welgus, H. and Kobayashi, D. and Pierce, R. and Shapiro, S. (1998) Matrix metalloproteinases generate angiostatin: Effects on neovascularization Journal of Immunology, 161, pp. 6845-6852. [CSA]
12. D'Amato, R. and Lin, C. and Flynn, E. and Folkman, J. and Hamel, E. (1994) 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site Proceedings of the National Academy of Sciences of the United States of America, 91, pp. 3964-3968. [INFOTRIEVE] [CSA]
13. D'Angelo, G. and Martini, J. and Iiri, T. and Fantl, W. and Martial, J. and Weiner, R. (1999) 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells Molecular Endocrinology, 13, pp. 692-704. [INFOTRIEVE] [CSA] [CROSSREF]
14. D'Angelo, G. and Struman, I. and Martial, J. and Weiner, R. (1995) Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin Proceedings of the National Academy of Sciences of the United States of America, 92, pp. 6374-6378. [INFOTRIEVE] [CSA]
15. Dawson, D. and Pearce, S. and Zhong, R. and Silverstein, R. and Frazier, W. and Bouck, N. (1997) CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells Journal of Cell Biology, 138, pp. 707-717. [INFOTRIEVE] [CSA] [CROSSREF]
16. Dawson, D. and Volpert, O. and Gillis, P. and Crawford, S. and Xu, H. and Benedict, W. and Bouck, N. (1999) Pigment epithelium-derived factor: A potent inhibitor of angiogenesis Science, 285, pp. 245-248. [INFOTRIEVE] [CSA] [CROSSREF]
17. Doll, J. and Stellmach, V. and Bouck, N. and Bergh, A. and Lee, C. and Abramson, L. and Cornwell, M. and Pins, M. and Borensztajn, J. and Crawford, S. (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas Nature Medicine, 9, pp. 774-780. [INFOTRIEVE] [CSA] [CROSSREF]
18. Dong, Z. and Kumar, R. and Yang, X. and Fidler, I. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma Cell, 88, pp. 801-810. [INFOTRIEVE] [CSA] [CROSSREF]
19. Eming, S. and Lauer, G. and Cole, M. and Jurk, S. and Christ, H. and Hornig, C. and Krieg, T. and Weich, H. (2004) Increased levels of the soluble variant of the vascular endothelial growth factor receptor VEGFR-1 are associated with a poor prognosis in wound healing Journal of Investigative Dermatology, 123, pp. 799-802. [INFOTRIEVE] [CSA] [CROSSREF]
20. Eubank, T. and Roberts, R. and Galloway, M. and Wang, Y. and Cohn, D and Marsh, C. (2004) GM-CSF induces expression of soluble VEGF receptor-1 from human monocytes and inhibits angiogenesis in mice Immunity, 1, pp. 831-842. [CSA] [CROSSREF]
21. Ferrara, N. and Clapp, C. and Weiner, R. (1991) The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells Endocrinology, 129, pp. 896-900. [INFOTRIEVE] [CSA]
22. Floquet, N. and Pasco, S. and Ramont, L. and Derreumaux, P. and Laronze, J. and Nuzillard, J. and Maquart, F. and Alix, A. and Monboisse, J. (2004) The antitumor properties of the α3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent Journal of Biological Chemistry, 279, pp. 2091-2100. [INFOTRIEVE] [CSA] [CROSSREF]
23. Fotsis, T. and Zhang, Y. and Pepper, M. and Adlercreutz, H. and Montesano, R. and Nawroth, P. and Schweigerer, L. (1994) The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth Nature, 368, pp. 237-239. [INFOTRIEVE] [CSA] [CROSSREF]
24. Geiger, J. and Cnudde, S. (2004) What the structure of angiostatin may tell us about its mechanism of action Journal of Thrombosis and Haemostasis, 2, pp. 23-34. [INFOTRIEVE] [CSA] [CROSSREF]
25. Gettins, P. and Simonovic, M. and Volz, K. (2002) Pigment epithelium-derived factor (PEDF), a serpin with potent anti-angiogenic and neurite outgrowth-promoting properties Biological Chemistry, 383, pp. 1677-1682. [INFOTRIEVE] [CSA] [CROSSREF]
26. Goldhar, A. and Vonderhaar, B. and Trott, J. and Hovey, R. (2005) Prolactin-induced expression of vascular endothelial growth factor via Egr-1 Molecular and Cellular Endocrinology, 232, pp. 9-19. [INFOTRIEVE] [CSA] [CROSSREF]
27. Hamano, Y. and Kalluri, R. (2005) Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth Biochemical and Biophysical Research Communications, 333, pp. 292-298. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
28. Harrington, E. and Loffler, J. and Nelson, P. and Kent, K. and Simons, M. and Ware, J. (1997) Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells Journal of Biological Chemistry, 272, pp. 7390-7397. [INFOTRIEVE] [CSA] [CROSSREF]
29. Heljasvaara, R. and Nyberg, P. and Luostarinen, J. and Parikka, M. and Heikkila, P. and Rehn, M. and Sorsa, T. and Salo, T. and Pihlajaniemi, T. (2005) Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases Experimental Cell Research, 307, pp. 292-304. [INFOTRIEVE] [CSA] [CROSSREF]
30. Hendrix, M. (2000) De-mystifying the mechanism(s) of maspin Nature Medicine, 6, pp. 374-376. [INFOTRIEVE] [CSA] [CROSSREF]
31. Hiraki, Y. and Kono, T. and Sato, M. and Shukunami, C. and Kondo, J. (1997) Inhibition of DNA synthesis and tube morphogenesis of cultured vascular endothelial cells by chondromodulin-I FEBS Letters, 415, pp. 321-324. [INFOTRIEVE] [CSA] [CROSSREF]
32. Hiraki, Y. and Shukunami, C. (2000) Chondromodulin-I as a novel cartilage-specific growth-modulating factor Pediatric Nephrology, 14, pp. 602-605. [INFOTRIEVE] [CSA] [CROSSREF]
33. Hiraki, Y. and Tanaka, H. and Inoue, H. and Kondo, J. and Kamizono, A. and Suzuki, F. (1991) Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes Biochemical and Biophysical Research Communications, 175, pp. 971-977. [INFOTRIEVE] [CSA] [CROSSREF]
34. Hirashima, M. and Lu, Y. and Byers, L. and Rossant, J. (2003) Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta Proceedings of the National Academy Sciences of the United States of America, 100, pp. 15637-15642. [CSA] [CROSSREF]
35. Hosomichi, J. and Yasui, N. and Koide, T. and Soma, K. and Morita, I. (2005) Involvement of the collagen I-binding motif in the anti-angiogenic activity of pigment epithelium-derived factor Biochemical and Biophysical Research Communications, 335, pp. 756-761. [INFOTRIEVE] [CSA] [CROSSREF]
36. Iruela-Arispe, M. and Luque, A. and Lee, N. (2004) Thrombospondin modules and angiogenesis International Journal of Biochemistry and Cell Biology, 36, pp. 1070-1078. [INFOTRIEVE] [CSA] [CROSSREF]
37. Kamphaus, G. and Colorado, P. and Panka, D. and Hopfer, H. and Ramchandran, R. and Torre, A. and Maeshima, Y. and Mier, J. and Sukhatme, V. and Kalluri, R. (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth Journal of Biological Chemistry, 275, pp. 1209-1215. [INFOTRIEVE] [CSA] [CROSSREF]
38. Karumanchi, S. and Jha, V. and Ramchandran, R. and Karihaloo, A. and Tsiokas, L. and Chan, B. and Dhanabal, M. and Hanai, J. and Venkataraman, G. and Shriver, Z. and Keiser, N. and Kalluri, R. and Zeng, H. and Mukhopadhyay, D. and Chen, R. and Lander, A. and Hagihara, K. and Yamaguchi, Y. and Sasisekharan, R. and Cantley, L. and Sukhatme, V. (2001) Cell surface glypicans are low-affinity endostatin receptors Molecular Cell, 7, pp. 811-822. [INFOTRIEVE] [CSA] [CROSSREF]
39. Kirsch, M. and Schackert, G. and Black, P. (2004) Metastasis and angiogenesis Cancer Treatment Research, 117, pp. 285-304. [CSA]
40. Kreuger, J. and Matsumoto, T. and Vanwildemeersch, M. and Sasaki, T. and Timpl, R. and Claesson-Welsh, L. and Spillmann, D. and Lindahl, U. (2002) Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function EMBO Journal, 21, pp. 6303-6311. [INFOTRIEVE] [CSA] [CROSSREF]
41. Larsson, H. and Akerud, P. and Nordling, K. and Raub-Segall, E. and Claesson-Welsh, L. and Bjork, I. (2001) A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity Journal of Biological Chemistry, 276, pp. 11996-12002. [INFOTRIEVE] [CSA] [CROSSREF]
42. Larsson, H. and Sjoblom, T. and Dixelius, J. and Ostman, A. and Ylinenjarvi, K. and Bjork, I. and Claesson-Welsh, L. (2000) Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells Cancer Research, 60, pp. 6723-6729. [INFOTRIEVE] [CSA]
43. Lijnen, H. and Ugwu, F. and Bini, A. and Collen, D. (1998) Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3) Biochemistry, 37, pp. 4699-4702. [INFOTRIEVE] [CSA] [CROSSREF]
44. Luster, A. and Unkeless, J. and Ravetch, J. (1985) Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins Nature, 315, pp. 672-676. [INFOTRIEVE] [CSA] [CROSSREF]
45. Mabjeesh, N. and Escuin, D. and LaVallee, T. and Pribluda, V. and Swartz, G. and Johnson, M. and Willard, M. and Zhong, H. and Simons, J. and Giannakakou, P. (2003) 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Cancer Cell, 3, pp. 363-375. [INFOTRIEVE] [CSA] [CROSSREF]
46. Maeshima, Y. and Colorado, P. and Kalluri, R. (2000a) Two RGD-independent α vβ3 integrin binding sites on tumstatin regulate distinct anti-tumor properties Journal of Biological Chemistry, 275, pp. 23745-23750. [INFOTRIEVE] [CSA] [CROSSREF]
47. Maeshima, Y. and Colorado, P. and Torre, A. and Holthaus, K. and Grunkemeyer, J. and Ericksen, M. and Hopfer, H. and Xiao, Y. and Stillman, I. and Kalluri, R. (2000a) Distinct anti-tumor properties of a type IV collagen domain derived from basement membrane Journal of Biological Chemistry, 275, pp. 21340-21348. [INFOTRIEVE] [CSA] [CROSSREF]
48. Maione, T. and Gray, G. and Petro, J. and Hunt, A. and Donner, A. and Bauer, S. and Carson, H. and Sharpe, R. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides Science, 247, pp. 77-79. [INFOTRIEVE] [CSA]
49. Maynard, S. and Min, J. and Merchan, J. and Lim, K. and Li, J. and Mondal, S. and Libermann, T. and Morgan, J. and Sellke, F. and Stillman, I. and Epstein, F. and Sukhatme, V. and Karumanchi, S. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia Journal of Clinical Investigation, 111, pp. 649-658. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
50. McGowen, R. and Biliran, H., Jr. and Sager, R. and Sheng, S. (2000) The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin Cancer Research, 60, pp. 4771-4778. [INFOTRIEVE] [CSA]
51. Michalak, M. and Milner, R. and Burns, K. and Opas, M. (1992) Calreticulin Biochemical Journal, 285, pp. 681-692. [INFOTRIEVE] [CSA]
52. Mori, Y. and Hiraki, Y. and Shukunami, C. and Kakudo, S. and Shiokawa, M. and Kagoshima, M. and Mano, H. and Hakeda, Y. and Kurokawa, T. and Suzuki, F. and Kumegawa, M. (1997) Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II FEBS Letters, 406, pp. 310-314. [INFOTRIEVE] [CSA]
53. Moser, T. and Stack, M. and Asplin, I. and Enghild, J. and Hojrup, P. and Everitt, L. and Hubchak, S. and Schnaper, H. and Pizzo, S. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells Proceedings of the National Academy of Sciences of the United States of America, 96, pp. 2811-2816. [INFOTRIEVE] [CSA] [CROSSREF]
54. Moses, M. (1993) A cartilage-derived inhibitor of neovascularization and metalloproteinases Clinical and Experimental Rheumatology, 11(Suppl 8), pp. S67-S69. [INFOTRIEVE] [CSA]
55. Nakamichi, Y. and Shukunami, C. and Yamada, T. and Aihara, K. and Kawano, H. and Sato, T. and Nishizaki, Y. and Yamamoto, Y. and Shindo, M. and Yoshimura, K. and Nakamura, T. and Takahashi, N. and Kawaguchi, H. and Hiraki, Y. and Kato, S. (2003) Chondromodulin I is a bone remodeling factor Molecular and Cellular Biology, 23, pp. 636-644. [INFOTRIEVE] [CSA] [CROSSREF]
56. Neville, L. and Mathiak, G. and Bagasra, O. (1997) The immunobiology of interferon-gamma inducible protein 10 kD (IP-10): A novel, pleiotropic member of the C-X-C chemokine superfamily Cytokine and Growth Factor Reviews, 8, pp. 207-219. [INFOTRIEVE] [CSA] [CROSSREF]
57. Noh, Y. and Matsuda, K. and Hong, Y. and Kunstfeld, R. and Riccardi, L. and Koch, M. and Oura, H. and Dadras, S. and Streit, M. and Detmar, M. (2003) An N-terminal 80 kDa recombinant fragment of human thrombospondin-2 inhibits vascular endothelial growth factor induced endothelial cell migration in vitro and tumor growth and angiogenesis in vivo Journal of Investigative Dermatology, 121, pp. 1536-1543. [INFOTRIEVE] [CSA] [CROSSREF]
58. O'Reilly, M. and Boehm, T. and Shing, Y. and Fukai, N. and Vasios, G. and Lane, W. and Flynn, E. and Birkhead, J. and Olsen, B. and Folkman, J. (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth Cell, 88, pp. 277-285. [INFOTRIEVE] [CSA] [CROSSREF]
59. O'Reilly, M. and Holmgren, L. and Shing, Y. and Chen, C. and Rosenthal, R. and Moses, M. and Lane, W. and Cao, Y. and Sage, E. and Folkman, J. (1994) Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell, 79, pp. 315-328. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
60. O'Reilly, M and Pirie-Shepherd, S. and Lane, W. and Folkman, J. (1999a) Antiangiogenic activity of the cleaved conformation of the serpin antithrombin Science, 285, pp. 1926-1928. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
61. O'Reilly, M. and Wiederschain, D. and Stetler-Stevenson, W. and Folkman, J. and Moses, M. (1999b) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance Journal of Biological Chemistry, 274, pp. 29568-29571. [INFOTRIEVE] [CSA] [CROSSREF]
62. Panka, D. and Mier, J. (2003) Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells Journal of Biologial Chemistry, 278, pp. 37632-37636. [CSA] [CROSSREF]
63. Patterson, B. and Sang, Q. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9) Journal of Biological Chemistry, 272, pp. 28823-28825. [INFOTRIEVE] [CSA] [CROSSREF]
64. Pike, S. and Yao, L. and Setsuda, J. and Jones, K. and Cherney, B. and Appella, E. and Sakaguchi, K. and Nakhasi, H. and Atreya, C. and Teruya-Feldstein, J. and Wirth, P. and Gupta, G. and Tosato, G. (1999) Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth Blood, 94, pp. 2461-2468. [INFOTRIEVE] [CSA]
65. Pozzi, A. and Wary, K. and Giancotti, F. and Gardner, H. (1998) Integrin α 1β 1 mediates a unique collagen-dependent proliferation pathway in vivo Journal of Cell Biology, 142, pp. 587-594. [INFOTRIEVE] [CSA] [CROSSREF]
66. Rodriguez-Manzaneque, J. and Lane, T. and Ortega, M. and Hynes, R. and Lawler, J. and Iruela-Arispe, M. (2001) Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor Proceedings of the National Acadeamy Science of United States of America, 98, pp. 12485-12490. [CSA] [CROSSREF]
67. Roemisch, J. and Gray, E. and Hoffmann, J. and Wiedermann, C. (2002) Antithrombin: A new look at the actions of a serine protease inhibitor Blood Coagulation and Fibrinolysis, 13, pp. 657-670. [INFOTRIEVE] [CSA] [CROSSREF]
68. Sasaki, T. and Larsson, H. and Kreuger, J. and Salmivirta, M. and Claesson-Welsh, L. and Lindahl, U. and Hohenester, E. and Timpl, R. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin EMBO Journal, 18, pp. 6240-6248. [INFOTRIEVE] [CSA] [CROSSREF]
69. Shen, J. and Yang, X. and Sato, Y. and Campochiaro, P. (2006) Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization FASEB Journal, 20, pp. 723-725. [INFOTRIEVE] [CSA]
70. Shibuya, T. and Watanabe, K. and Yamashita, H. and Shimizu, K. and Miyashita, H. and Abe, M. and Moriya, T. and Ohta, H. and Sonoda, H. and Shimosegawa, T. and Tabayashi, K. and Sato, Y. (2006) Isolation of vasohibin-2 as a sole homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin: A comparative study on their expressions Arteriosclerosis, Thrombosis, and Vascular Biology, 26, pp. 1051-1057. [INFOTRIEVE] [CSA] [CROSSREF]
71. Shimizu, K. and Watanabe, K. and Yamashita, H. and Abe, M. and Yoshimatsu, H. and Ohta, H. and Sonoda, H. and Sato, Y. (2005) Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells Biochemical and Biophysical Research Communications, 327, pp. 700-706. [INFOTRIEVE] [CSA] [CROSSREF]
72. Sidky, Y. and Borden, E. (1987) Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses Cancer Research, 47, pp. 5155-5161. [INFOTRIEVE] [CSA]
73. Sim, B. and MacDonald, N. and Gubish, E. (2000) Angiostatin and endostatin: Endogenous inhibitors of tumor growth Cancer and Metastasis Reviews, 19, pp. 181-190. [INFOTRIEVE] [CSA] [CROSSREF]
74. Slaton, J. and Karashima, T. and Perrotte, P. and Inoue, K. and Kim, S and Izawa, J. and Kedar, D. and McConkey, D. and Millikan, R. and Sweeney, P. and Yoshikawa, C. and Shuin, T. and Dinney, C. (2001) Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder Clinical Cancer Research, 7, pp. 2840-2853. [INFOTRIEVE] [CSA]
75. Slaton, J. and Perrotte, P. and Inoue, K. and Dinney, C. and Fidler, I. (1999) Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule Clinical Cancer Research, 5, pp. 2726-2734. [INFOTRIEVE] [CSA]
76. Stathakis, P. and Fitzgerald, M. and Matthias, L. and Chesterman, C. and Hogg, P. (1997) Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells Journal of Biological Chemistry, 272, pp. 20641-20645. [INFOTRIEVE] [CSA] [CROSSREF]
77. Steele, F. and Chader, G. and Johnson, L. and Tombran-Tink, J. (1993) Pigment epithelium-derived factor: Neurotrophic activity and identification as a member of the serine protease inhibitor gene family Proceedings of the National Academy of the Sciences of the United States of America, 90, pp. 1526-1530. [CSA]
78. Stetler-Stevenson, W. and Seo, D. (2005) TIMP-2: An endogenous inhibitor of angiogenesis Trends in Molecular Medicine, 11, pp. 97-103. [INFOTRIEVE] [CSA] [CROSSREF]
79. Streit, M. and Velasco, P. and Brown, L. and Skobe, M. and Richard, L. and Riccardi, L. and Lawler, J. and Detmar, M. (1999) Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas American Journal of Pathology, 155, pp. 441-452. [INFOTRIEVE] [CSA]
80. Struman, I. and Bentzien, F. and Lee, H. and Mainfroid, V. and D'Angelo, G. and Goffin, V. and Weiner, R. and Martial, J. (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis Proceedings of the National Academy of the Sciences of the United States of America, 96, pp. 1246-1251. [CSA] [CROSSREF]
81. Sudhakar, A. and Sugimoto, H. and Yang, C. and Lively, J. and Zeisberg, M. and Kalluri, R. (2003) Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins Proceedings of the National Academy of Sciences United States of America, 100, pp. 4766-4771. [CSA] [CROSSREF]
82. Tarui, T. and Majumdar, M. and Miles, L. and Ruf, W. and Takada, Y. (2002) Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin Journal of Biological Chemistry, 277, pp. 33564-33570. [INFOTRIEVE] [CSA] [CROSSREF]
83. Tarui, T. and Miles, L. and Takada, Y. (2001) Specific interaction of angiostatin with integrin αvβ3 in endothelial cells Journal of Biological Chemistry, 276, pp. 39562-39568. [INFOTRIEVE] [CSA] [CROSSREF]
84. Troyanovsky, B. and Levchenko, T. and Mansson, G. and Matvijenko, O. and Holmgren, L. (2001) Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation Journal of Cell Biology, 152, pp. 1247-1254. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
85. Vlodavsky, I. and Korner, G. and Ishai-Michaeli, R. and Bashkin, P. and Bar-Shavit, R. and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: Possible involvement in tumor metastasis and angiogenesis Cancer and Metastasis Reviews, 9, pp. 203-226. [INFOTRIEVE] [CSA] [CROSSREF]
86. Volpert, O. and Zaichuk, T. and Zhou, W. and Reiher, F. and Ferguson, T. and Stuart, P. and Amin, M. and Bouck, N. (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor Natural Medicine, 8, pp. 349-357. [CSA] [CROSSREF]
87. von Marschall, Z. and Scholz, A. and Cramer, T. and Schafer, G. and Schirner, M. and Oberg, K. and Wiedenmann, B. and Hocker, M. and Rosewicz, S. (2003) Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis Journal of the National Cancer Institute, 95, pp. 437-448. [PUBMED] [INFOTRIEVE] [CSA]
88. Watanabe, K. and Hasegawa, Y. and Yamashita, H. and Shimizu, K. and Ding, Y. and Abe, M. and Ohta, H. and Imagawa, K. and Hojo, K. and Maki, H. and Sonoda, H. and Sato, Y. (2004) Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis Journal of Clinical Investigation, 114, pp. 898-907. [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
89. Wickstrom, S. and Alitalo, K. and Keski-Oja, J. (2004) An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells Journal of Biological Chemistry, 279, pp. 20178-20185. [INFOTRIEVE] [CSA] [CROSSREF]
90. Yamaguchi, S. and Iwata, K. and Shibuya, M. (2002) Soluble Flt-1 (soluble VEGFR-1), a potent natural antiangiogenic molecule in mammals, is phylogenetically conserved in avians Biochemical and Biophysical Research Communications, 291, pp. 554-559. [INFOTRIEVE] [CSA] [CROSSREF]
91. Yang, Q. and Rasmussen, S. and Friedman, J. (2002) Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study Lancet, 359, pp. 1019-1025. [INFOTRIEVE] [CSA] [CROSSREF]
92. Yang, J. and Richmond, A. (2004) The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan Molecular Therapy, 9, pp. 846-855. [INFOTRIEVE] [CSA] [CROSSREF]
93. Yao, L. and Pike, S. and Tosato, G. (2002) Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function Journal of Leukocyte Biology, 71, pp. 47-53. [INFOTRIEVE] [CSA]
94. Zhang, D. and Kaufman, P. and Gao, G. and Saunders, R. and Ma, J. (2001) Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats Diabetologia, 44, pp. 757-765. [INFOTRIEVE] [CSA] [CROSSREF]
95. Zhang, M. and Volpert, O. and Shi, Y. and Bouck, N. (2000) Maspin is an angiogenesis inhibitor Natural Medicine, 6, pp. 196-199. [CSA] [CROSSREF]
96. Zhang, W. and Chuang, Y. and Swanson, R. and Li, J. and Seo, K. and Leung, L. and Lau, L. and Olson, S. (2004) Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells Blood, 103, pp. 1185-1191. [INFOTRIEVE] [CSA] [CROSSREF]
97. Zhou, J. and Giannakakou, P. (2005) Targeting microtubules for cancer chemotherapy Current Medicinal Chemistry and Anti-Cancer Agents, 5, pp. 65-71. [CSA] [CROSSREF]
98. Zorick, T. and Mustacchi, Z. and Bando, S and Zatz, M. and Moreira-Filho, C. and Olsen, B. and Passos-Bueno, M. (2001) High serum endostatin levels in Down syndrome: Implications for improved treatment and prevention of solid tumours European Journal of Human Genetics, 9, pp. 811-814. [INFOTRIEVE] [CSA]
99. Zou, Z. and Anisowicz, A. and Hendrix, M. and Thor, A. and Neveu, M. and Sheng, S. and Rafidi, K. and Seftor, E. and Sager, R. (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells Science, 263, pp. 526-529. [PUBMED] [INFOTRIEVE] [CSA]
100. Zou, Z. and Gao, C. and Nagaich, A. and Connell, T. and Saito, S. and Moul, J. and Seth, P. and Appella, E. and Srivastava, S. (2000) p53 regulates the expression of the tumor suppressor gene maspin Journal of Biological Chemistry, 275, pp. 6051-6054. [INFOTRIEVE] [CSA] [CROSSREF]